|
Back
A Double-blind Randomized Homeopathic Remedy Proving with Healthy Individuals:
Comparison of Two High Potencies (C30)
Principal Investigators: H. Möllinger, MD; H. Walach, PhD
Affiliations: Gesundheitszentrum Sokrates, Güttingen, Switzerland; University
Hospital Freiburg, Department of Environmental Medicine and Hospital
Epidemiology
Background: Homeopathic remedy proving with healthy individuals is one of the
basic prerequisites for homeopathic therapy. However, until now there is no
evidence that the symptoms elicited in a homeopathic remedy proving actually
differ from those of placebo.
Objective of the study: To compare two homeopathic high potencies which
previously have not been thoroughly tested, but which may more readily differ in
their symptoms when compared to each other than when compared with placebo.
Methods: This homeopathic remedy proving will be prospective, randomized, and
double-blind with parallel groups. There will be two groups: Group A (Freiburg
group) with physicians trained in homeopathy and experienced with remedy
provings, and group B (Swiss group) with physicians trained in homeopathy, but
with no or little experience in remedy provings. Randomization will be performed
by a supervisor. The two main goals of the study are to determine whether the
symptoms tested in the remedy provings are specific for the remedy, and whether
the symptoms can be assigned to the two remedies and the placebo, respectively.
Symptoms will be analyzed according to the repertory by Kent, the most common
tool for symptom analysis in homeopathy. In addition, intensity, frequency, and
modalities will be considered.
Relationship to SIIB Mission and Healing: Homeopathy has suffered from a dearth
of solidly constructed scientific studies in provings which consisted of
randomization and double blinding. This research will contribute to a more
thorough and rigorous analysis of the proving process.
|